Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
The purpose of this study is to determine whether psilocybin, a hallucinogenic drug, is effective in reducing depressive symptoms and amount of drinking in patients with co-occurring Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).
Epistemonikos ID: 06ddb2170920a53af364161600980fb610132e8d
First added on: Oct 02, 2023